Laura Stevens is a Senior Scientist at AstraZeneca, focusing on the evolution of drug resistance in cancer. They earned a Ph.D. in Experimental Pathology from Yale University, where their thesis investigated mechanisms of micrometastatic outgrowth in lung adenocarcinoma. Following their doctorate, Stevens served as a postdoctoral research fellow at Dana-Farber Cancer Institute, contributing to research on therapeutic resistance in inflammatory breast cancer and mentoring students along the way.
This person is not in the org chart
This person is not in any teams
This person is not in any offices